Metraipolis › archive › dc_99765a26cf82

Efficacy and safety of obinutuzumab in primary membranous nephropathy: a real-world retrospective study — Europe PMC PMID:40918120

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40918120
DOI
10.3389/fimmu.2025.1650054
License (as archived)
solo-consultazione
Archived
2026-11-10T11:17:51.380Z
SHA-256 of the archived text
412aab2d58fe61f6c6768975e0a3ce3cd456451e019558cab5d604450b23d30f
Stable URL of this page
https://metraipolis.com/documento/dc_99765a26cf82

How to cite

Efficacy and safety of obinutuzumab in primary membranous nephropathy: a real-world retrospective study — Europe PMC PMID:40918120 — Europe PMC (en), https://europepmc.org/article/MED/40918120 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_99765a26cf82 (Metraipolis archive dc_99765a26cf82, sha256 412aab2d58fe61f6c6768975e0a3ce3cd456451e019558cab5d604450b23d30f)
BibTeX
@misc{dc99765a26cf82,
  title = {Efficacy and safety of obinutuzumab in primary membranous nephropathy: a real-world retrospective study — Europe PMC PMID:40918120},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40918120},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_99765a26cf82; sha256 412aab2d58fe61f6c6768975e0a3ce3cd456451e019558cab5d604450b23d30f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40918120. Agents can read the archived copy with the MCP tool read_document.